2026

Case Study

Revilico Virtual Cell Engine: Cross-Cell-Line Drug Response Benchmarking

Evaluating the Virtual Cell’s ability to predict half-maximal inhibitory concentration (IC50) across diverse cancer cell lines and structurally novel compounds, using publicly available drug sensitivity data and prospective experimental cell viability assay validation.

If the PDF doesn’t display, open it in a new tab or download it.

The Final Operating System of Pharma.

909.267.0577

3680 Wilshire Blvd
P04-1343 Los Angeles
CA 90010

Revilico 2026

The Final Operating System of Pharma.

909.267.0577

3680 Wilshire Blvd
P04-1343 Los Angeles
CA 90010

Revilico 2026